EU AI Act Governance Readiness for Hospitals

Preparing Clinical AI Systems for the European Regulatory Framework

Executive Briefing — Dr R.R. Goerdin, Founder — Lifecycle Governance™

Hospitals across Europe are increasingly exploring artificial intelligence in areas such as diagnostics, clinical decision support, and operational optimisation. While these technologies offer significant potential benefits, they also introduce new governance responsibilities.

The EU Artificial Intelligence Act establishes a risk-based regulatory framework designed to ensure the safe and trustworthy use of AI systems across the European Union. Many healthcare AI applications are expected to fall within the high-risk category, requiring organisations deploying these systems to implement structured governance, oversight, and risk management procedures.

This executive briefing provides a practical overview for hospital leaders evaluating governance readiness.

Artificial intelligence is becoming increasingly integrated into healthcare delivery. Hospitals are exploring AI applications across radiology, pathology, clinical decision support, patient triage, and operational management.

At the same time, regulatory frameworks governing AI are rapidly evolving. The EU AI Act introduces obligations for organisations that develop, deploy, or operate certain categories of AI systems.

Key considerations for hospitals include:

• —identifying AI systems currently in use or under evaluation
• —assessing whether those systems may fall within the high-risk classification
• —establishing governance mechanisms for oversight and accountability
• —ensuring documentation and monitoring structures are in place

Many healthcare organisations are still at an early stage in building structured governance frameworks for clinical AI systems. As regulatory expectations evolve, hospitals may benefit from evaluating governance readiness and identifying areas where additional oversight structures may be required.

Artificial intelligence technologies are being evaluated across a wide range of clinical and operational domains.

Examples include:

Diagnostic support AI systems assisting clinicians in interpreting radiology or pathology images.

Clinical decision support Algorithms providing recommendations based on patient data.

Patient triage systems AI tools assisting in prioritising patients or predicting deterioration.

Remote patient monitoring Machine-learning systems identifying early warning signals from patient data streams.

Operational optimisation Algorithms supporting scheduling, workflow management, or hospital logistics.

While these technologies may improve efficiency and clinical insight, their integration into healthcare environments raises questions regarding safety, transparency, and clinical accountability.

The EU AI Act introduces a risk-based classification system for AI technologies.

Certain AI systems that influence decisions affecting health and safety may be classified as high-risk.

Examples potentially falling within this category may include:

• —AI diagnostic support systems
• —clinical decision support algorithms
• —patient triage or prioritisation tools
• —predictive monitoring systems affecting treatment decisions

High-risk systems may require additional governance measures such as:

• —risk management processes
• —human oversight mechanisms
• —documentation and transparency requirements
• —monitoring of system performance over time

The precise classification of any AI system depends on its intended use and clinical context.

Many hospitals currently face structural challenges when integrating AI technologies into clinical practice.

Common governance gaps may include:

Limited AI inventory Hospitals may not have a consolidated overview of AI systems deployed across departments.

Fragmented oversight Responsibility for AI systems may be distributed between IT departments, clinical teams, and external vendors.

Unclear accountability structures Governance roles and responsibilities may not yet be clearly defined.

Limited monitoring frameworks Post-deployment monitoring processes for AI systems may not be formally established.

Addressing these governance questions early may support both regulatory readiness and safe clinical integration.

Hospitals may benefit from establishing a structured oversight framework for AI systems.

A typical governance model may include:

Board or executive oversight Strategic oversight of AI adoption and governance policies.

AI governance committee A multidisciplinary group responsible for evaluating and overseeing AI systems.

Clinical leadership Ensuring clinical relevance and patient safety considerations.

Information technology governance Managing technical integration and system performance.

Compliance and legal oversight Ensuring alignment with regulatory obligations and institutional policies.

Such governance structures allow hospitals to maintain transparency and accountability as AI technologies expand across clinical workflows.

Hospitals evaluating AI governance readiness may consider a phased approach.

Phase 1 — AI System Inventory Identify AI technologies currently deployed or under evaluation across departments.

Phase 2 — Risk Classification Assess potential regulatory classification based on system function and clinical context.

Phase 3 — Governance Framework Define oversight structures, roles, and decision-making processes.

Phase 4 — Oversight Committee Establish a formal governance body responsible for AI system evaluation.

Phase 5 — Continuous Monitoring Implement procedures for monitoring system performance and updating governance policies.

This phased approach allows organisations to gradually build governance capacity while maintaining operational continuity.

Hospitals exploring governance readiness may benefit from an initial AI Governance QuickScan.

The QuickScan provides a structured overview of key governance considerations, including:

• —AI system inventory and mapping
• —potential regulatory risk categories
• —evaluation of existing governance structures
• —identification of potential readiness gaps

The outcome typically includes:

• —a governance readiness overview
• —recommendations for oversight structures
• —suggested next steps for implementation

This assessment can provide hospital leadership with a practical starting point for evaluating AI governance frameworks.

Lifecycle Governance™ focuses on governance frameworks supporting the responsible integration of artificial intelligence in healthcare organisations.

The initiative explores practical governance models that help hospitals evaluate AI technologies while maintaining clinical oversight and institutional accountability.

Further information and executive briefings are available upon request.